National Health Investors Analyst Ratings
National Health Investors Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/28/2023 | 1.1% | Stifel | → $55 | Reiterates | Hold → Hold |
11/27/2023 | 1.1% | Wells Fargo | $54 → $55 | Maintains | Equal-Weight |
10/03/2023 | -0.74% | Wedbush | → $54 | Initiates Coverage On | → Neutral |
09/28/2023 | — | Berenberg | Initiates Coverage On | → Hold | |
09/20/2023 | -4.41% | Jefferies | → $52 | Initiates Coverage On | → Hold |
05/11/2023 | -0.74% | Wells Fargo | $52 → $54 | Maintains | Equal-Weight |
03/29/2023 | -8.09% | Credit Suisse | $55 → $50 | Maintains | Neutral |
12/09/2022 | 6.62% | Credit Suisse | $47 → $58 | Upgrades | Underperform → Neutral |
09/26/2022 | 12.13% | Truist Securities | $64 → $61 | Maintains | Hold |
06/21/2022 | 13.97% | BMO Capital | → $62 | Downgrades | Outperform → Market Perform |
04/19/2022 | 12.13% | BMO Capital | $63 → $61 | Maintains | Outperform |
02/01/2022 | -6.25% | Credit Suisse | → $51 | Initiates Coverage On | → Underperform |
01/07/2022 | 25% | BMO Capital | → $68 | Upgrades | Market Perform → Outperform |
07/23/2021 | 32.35% | Wells Fargo | $74 → $72 | Maintains | Equal-Weight |
06/18/2021 | 30.51% | BMO Capital | → $71 | Upgrades | Underperform → Market Perform |
03/30/2021 | 41.54% | Capital One | → $77 | Downgrades | Overweight → Equal-Weight |
01/13/2021 | 1.1% | Mizuho | → $55 | Downgrades | Neutral → Underperform |
01/08/2021 | — | BMO Capital | Downgrades | Market Perform → Underperform | |
12/14/2020 | — | Keybanc | Upgrades | Underweight → Sector Weight | |
09/02/2020 | 15.81% | Stifel | → $63 | Reinstates | → Hold |
06/24/2020 | 17.65% | SunTrust Robinson Humphrey | $61 → $64 | Maintains | Hold |
06/17/2020 | 21.32% | Wells Fargo | $54 → $66 | Maintains | Equal-Weight |
06/08/2020 | — | JMP Securities | Reinstates | → Market Perform | |
05/22/2020 | 1.1% | Mizuho | $60 → $55 | Downgrades | Buy → Neutral |
05/14/2020 | -26.47% | Keybanc | $43 → $40 | Maintains | Underweight |
04/23/2020 | 12.13% | SunTrust Robinson Humphrey | $77 → $61 | Maintains | Hold |
04/21/2020 | -20.96% | Keybanc | $65 → $43 | Maintains | Underweight |
03/26/2020 | -6.25% | Wells Fargo | $82 → $51 | Maintains | Equal-Weight |
02/05/2020 | — | Berenberg | Initiates Coverage On | → Buy | |
01/07/2020 | 50.74% | BMO Capital | → $82 | Upgrades | Underperform → Market Perform |
12/20/2019 | 74.63% | Mizuho | → $95 | Assumes | → Buy |
02/20/2019 | — | BMO Capital | Downgrades | Market Perform → Underperform |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
11/28/2023 | 1.1% | Stifel | → 55 美元 | 重申 | 按住 → 按住 |
11/27/2023 | 1.1% | 富國銀行 | 54 美元 → 55 美元 | 維護 | 重量相等 |
2023 年 3 月 10 日 | -0.74% | Wedbush | → 54 美元 | 啓動覆蓋範圍開啓 | → 中立 |
09/28/2023 | — | 貝倫貝格 | 啓動覆蓋範圍開啓 | → 按住 | |
09/20/2023 | -4.41% | 傑富瑞集團 | → 52 美元 | 啓動覆蓋範圍開啓 | → 按住 |
05/11/2023 | -0.74% | 富國銀行 | 52 美元 → 54 美元 | 維護 | 重量相等 |
03/29/2023 | -8.09% | 瑞士信貸 | 55 美元 → 50 美元 | 維護 | 中立 |
2022 年 9 月 12 日 | 6.62% | 瑞士信貸 | 47 美元 → 58 美元 | 升級 | 表現不佳 → 中性 |
09/26/2022 | 12.13% | Truist 證券 | 64 美元 → 61 美元 | 維護 | 保持 |
2022 年 6 月 21 日 | 13.97% | BMO Capital | → 62 美元 | 降級 | 跑贏大盤 → 市場表現 |
04/19/2022 | 12.13% | BMO Capital | 63 美元 → 61 美元 | 維護 | 跑贏大盤 |
2022 年 1 月 2 日 | -6.25% | 瑞士信貸 | → 51 美元 | 啓動覆蓋範圍開啓 | → 表現不佳 |
2022 年 7 月 1 日 | 25% | BMO Capital | → 68 美元 | 升級 | 市場表現 → 跑贏大盤 |
2021 年 7 月 23 日 | 32.35% | 富國銀行 | 74 美元 → 72 美元 | 維護 | 重量相等 |
06/18/2021 | 30.51% | BMO Capital | → 71 美元 | 升級 | 表現不佳 → 市場表現 |
03/30/2021 | 41.54% | 第一資本 | → 77 美元 | 降級 | 超重 → 重量相等 |
2021 年 1 月 13 日 | 1.1% | 瑞穗市 | → 55 美元 | 降級 | 中性 → 跑贏大盤 |
01/08/2021 | — | BMO Capital | 降級 | 市場表現 → 表現不佳 | |
2020 年 12 月 14 日 | — | Keybanc | 升級 | 減持 → 行業權重 | |
2020 年 2 月 9 日 | 15.81% | Stifel | → 63 美元 | 恢復 | → 按住 |
06/24/2020 | 17.65% | SunTrust 羅賓遜·漢弗萊 | 61 美元 → 64 美元 | 維護 | 保持 |
2020 年 6 月 17 日 | 21.32% | 富國銀行 | 54 美元 → 66 美元 | 維護 | 重量相等 |
06/08/2020 | — | JMP 證券 | 恢復 | → 市場表現 | |
05/22/2020 | 1.1% | 瑞穗市 | 60 美元 → 55 美元 | 降級 | 買入 → 中性 |
05/14/2020 | -26.47% | Keybanc | 43 美元 → 40 美元 | 維護 | 體重不足 |
04/23/2020 | 12.13% | SunTrust 羅賓遜·漢弗萊 | 77 美元 → 61 美元 | 維護 | 保持 |
2020 年 4 月 21 日 | -20.96% | Keybanc | 65 美元 → 43 美元 | 維護 | 體重不足 |
2020 年 3 月 26 日 | -6.25% | 富國銀行 | 82 美元 → 51 美元 | 維護 | 重量相等 |
02/05/2020 | — | 貝倫貝格 | 啓動覆蓋範圍開啓 | → 購買 | |
01/07/2020 | 50.74% | BMO Capital | → 82 美元 | 升級 | 表現不佳 → 市場表現 |
12/20/2019 | 74.63% | 瑞穗市 | → 95 美元 | 假設 | → 購買 |
02/20/2019 | — | BMO Capital | 降級 | 市場表現 → 表現不佳 |
What is the target price for National Health Investors (NHI)?
國民健康投資者(NHI)的目標價格是多少?
The latest price target for National Health Investors (NYSE: NHI) was reported by Stifel on November 28, 2023. The analyst firm set a price target for $55.00 expecting NHI to rise to within 12 months (a possible 1.10% upside). 8 analyst firms have reported ratings in the last year.
Stifel於2023年11月28日公佈了國家健康投資者(紐約證券交易所代碼:NHI)的最新目標股價。該分析公司將目標股價定爲55.00美元,預計NHI將在12個月內升至12個月內(可能上漲1.10%)。去年有8家分析公司公佈了評級。
What is the most recent analyst rating for National Health Investors (NHI)?
國家健康投資者(NHI)的最新分析師評級是多少?
The latest analyst rating for National Health Investors (NYSE: NHI) was provided by Stifel, and National Health Investors reiterated their hold rating.
Stifel提供了National Health Investors(紐約證券交易所代碼:NHI)的最新分析師評級,國民健康投資者重申了持有評級。
When is the next analyst rating going to be posted or updated for National Health Investors (NHI)?
國家健康投資者(NHI)的下一次分析師評級何時公佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of National Health Investors, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for National Health Investors was filed on November 28, 2023 so you should expect the next rating to be made available sometime around November 28, 2024.
分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表,與National Health Investors的高管和客戶交談,以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級,因此每家公司每年應該獲得4次評級。National Health Investors的最新評級是在2023年11月28日公佈的,因此您應該預計下一個評級將在2024年11月28日左右公佈。
Is the Analyst Rating National Health Investors (NHI) correct?
分析師對國民健康投資者(NHI)的評級是否正確?
While ratings are subjective and will change, the latest National Health Investors (NHI) rating was a reiterated with a price target of $0.00 to $55.00. The current price National Health Investors (NHI) is trading at is $54.40, which is within the analyst's predicted range.
儘管評級是主觀的,並且會發生變化,但重申了最新的國家健康投資者(NHI)評級,目標股價爲0.00美元至55.00美元。國家健康投資者(NHI)目前的交易價格爲54.40美元,在分析師的預測區間內。